Predictors of early recurrence of benign esophageal strictures

American Journal of Gastroenterology

Volumn 98, Issue 6, 2003, Pages 1252-1256

  Said, Adnan ^a   Brust, Donald J ^a   Gaumnitz, Eric A ^a   Reichelderfer, Mark ^a  

^a University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ARTICLE; CONTROLLED STUDY; DYSPHAGIA; ENDOSCOPIC THERAPY; ESOPHAGUS PH; ESOPHAGUS STRICTURE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HIATUS HERNIA; HUMAN; MAJOR CLINICAL STUDY; PH MEASUREMENT; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR;

EID: 0038310903     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2003.07490.x     Document Type: Article

References (19)

1. Marks RD, Richter JE, Rizzo J, et al. Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis. Gastroenterology 1994;106:907-15.
2. Smith PM, Kerr GD, Cockel R, et al. A comparison of omeprazole and ranitidine in the prevention of recurrence of benign esophageal stricture. Restore Investigator Group. Gastroenterology 1994;107:1312-8.
3. Saeed ZA, Ramirez FC, Hepps KS, et al. An objective end point for dilation improves outcome of peptic esophageal strictures: A prospective randomized trial. Gastrointest Endosc 1997;45:354-9.
4. Patterson DJ, Graham DY, Smith JL, et al. Natural history of benign esophageal stricture treated by dilatation. Gastroenterology 1983;85:346-50.
5. Agnew SR, Pandya SP, Reynolds RP. Predictors for frequent esophageal dilations of benign peptic strictures. Dig Dis Sci 1996;41:931-6.
6. Glick ME. Clinical course of esophageal stricture managed by bougienage. Dig Dis Sci 1982;27:884-8.
7. Richter JE. Peptic strictures of the esophagus. Gastroenterol Clin North Am 1999;28:875-91.
8. Pereira-Lima JC, Ramires RP, Zamin I Jr, et al. Endoscopic dilation of benign esophageal strictures: Report on 1043 procedures. Am J Gastroenterol 1999;94:1497-501.
9. Armstrong D, Bennett JR, Blum AL, et al. The endoscopic assessment of esophagitis: A progress report on observer agreement. Gastroenterology 1996;111:85-92.
10. Dakkak M, Hoare RC, Maslin SC, Bennett JR. Oesophagitis is as important as oesophageal stricture diameter in determining dysphagia. Gut 1993;34:152-5.
11. Stein HJ, Barlow AP, DeMeester TR, Hinder, RA. Complications of gastroesophageal reflux disease. Role of the lower esophageal sphincter, esophageal acid and acid/alkaline exposure, and duodenogastric reflux. Ann Surg 1992;216:35-43.
12. Cohen S, Harris LD. Does hiatus hernia affect competence of the gastroesophageal sphincter? N Engl J Med 1971;284:1053-6.
13. Berstad A, Weberg R, Froyshov Larsen I, et al. Relationship of hiatus hernia to reflux oesophagitis. A prospective study of coincidence, using endoscopy. Scand J Gastroenterol 1986;21:55-8.
14. Pandolfino JE, Shi G, Curry J, et al. Esophagogastric junction distensibility: A factor contributing to sphincter incompetence. Am J Physiol Gastrointest Liver Physiol 2002;282:G1052-8.
15. Vasilopoulos S, Murphy P, Auerbach A, et al. The small-caliber esophagus: An unappreciated cause of dysphagia for solids in patients with eosinophilic esophagitis. Gastrointest Endosc 2002;55:99-106.
16. Kozarek RA. Proximal strictures of the esophagus. J Clin Gastroenterol 1984;6:505-11.
17. Lee M, Kubik CM, Polhamus CD, et al. Preliminary experience with endoscopic intralesional steroid injection therapy for refractory upper gastrointestinal strictures. Gastrointest Endosc 1995;41:598-601.
18. Zein NN, Greseth JM, Perrault J. Endoscopic intralesional steroid injections in the management of refractory esophageal strictures. Gastrointest Endosc 1995;41:596-8.
19. Katzka DA, Paoletti V, Leite L, Castell DO. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: Testing while on therapy identifies the need for more aggressive anti-reflux therapy. Am J Gastroenterol 1996;91:2110-3.